Yun Jung Heo

Yun Jung Heo


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2023 in Science Advances
Verified
Journal Article
Open access
MSMingyu Sang
Mingyu Sang
MCMyeongki Cho
Myeongki Cho
SLSelin Lim
Selin Lim
IMIn Sik Min
In Sik Min
YHYuna Han
Yuna Han
Ki Jun YuKi Jun Yu
Ki Jun Yu
Continuous glucose monitoring (CGM) allows patients with diabetes to manage critical disease effectively and autonomously and prevent exacerbation. A painless, wireless, compact, and minimally invasive device that can provide CGM is essential for monitoring the health conditions of freely moving patients with diabetes. Here, we propose a glucose-responsive fluorescence-based highly sensitive biodegradable microneedle CGM system. These ultrathin and ultralight microneedle sensor arrays continuously and precisely monitored glucose concentration in the interstitial fluid with minimally invasive, pain-free, wound-free, and skin inflammation–free outcomes at various locations and thicknesses of the skin. Bioresorbability in the body without a need for device removal after use was a key characteristic of the microneedle glucose sensor. We demonstrated the potential long-term use of the bioresorbable device by applying the tether-free CGM system, thus confirming the successful detection of glucose levels based on changes in fluorescence intensity. In addition, this microneedle glucose sensor with a user-friendly designed home diagnosis system using mobile applications and portable accessories offers an advance in CGM and its applicability to other bioresorbable, wearable, and implantable monitoring device technology.

27 May 2019 in Applied Sciences
Verified
Journal Article
Open access
PDF file
YHYun Jung Heo
Yun Jung Heo
SKSeong-Hyok Kim
Seong-Hyok Kim
Continuous glucose monitoring (CGM) sensors have led a paradigm shift to painless, continuous, zero-finger pricking measurement in blood glucose monitoring. Recent electrochemical CGM sensors have reached two-week lifespans and no calibration with clinically acceptable accuracy. The system with the recent CGM sensors is identified as an “integrated glucose monitoring system,” which can replace finger-pricking glucose-testing for diabetes treatment decisions. Although such innovation has brought CGM technology closer to realizing the artificial pancreas, discomfort and infection problems have arisen from short lifespans and open wounds. A fully implantable sensor with a longer-term lifespan (90 days) is considered as an alternative CGM sensor with high comfort and low running cost. However, it still has barriers, including surgery for applying and replacing and frequent calibration. If technical refinement is conducted (e.g., stability and reproducibility of sensor fabrication), fully implantable, long-term CGM sensors can open the new era of continuous glucose monitoring.

22 February 2021 in BioChip Journal
Verified
Journal Article
Closed access
PDF file
MPMin Park
Min Park
YHYun Jung Heo
Yun Jung Heo

3 June 2024 in Soft Matter
Verified
Journal Article
Open access
PDF file
APAkash Ranjan Pati
Akash Ranjan Pati
YKYoung-Su Ko
Young-Su Ko
CBChangwoo Bae
Changwoo Bae
ICInhee Choi
Inhee Choi
YHYun Jung Heo
Yun Jung Heo
CLChoongyeop Lee
Choongyeop Lee
This study introduces a facile method for fabricating hydrophilic 3D-network hydrogels, integrating plasmonic gold nanoparticles to boost solar absorption, enhancing evaporation rates and solar efficiency to 1.6 kg m−2 h−1 and 77%, respectively.

24 August 2024 in Talanta
Verified
Journal Article
Open access
JKJeeYoung Kim
JeeYoung Kim
MKMi Yeon Kim
Mi Yeon Kim
YHYuna Han
Yuna Han
GLGa Yeong Lee
Ga Yeong Lee
DKDa Hyeon Kim
Da Hyeon Kim
Min ParkMin Park
Min Park
In this study, we present the development of an innovative electrochemical biosensor integrated into a microneedle-based system for non-invasive and sensitive quantification of cholesterol levels in interstitial fluid (ISF). The biosensor employs a graphene-based electrode with a polyelectrolyte interlayer to immobilize cholesterol oxidase (ChOx), enabling selective cholesterol detection. Graphene oxide is electrochemically reduced to form a conductive layer, and PANI is chosen as the optimal polyelectrolyte for ChOx immobilization. The biosensor's performance is thoroughly evaluated, demonstrating excellent sensitivity, stability, and selectivity. Furthermore, the biosensor is successfully applied to skin-mimicking agarose gel and porcine skin, showcasing its potential for real-world interstitial fluid extraction and cholesterol monitoring. The integrated microneedle-based system offers a promising approach for non-invasive monitoring of cholesterol levels, with implications for personalized healthcare diagnostics.

15 July 2021 in Sensors
Verified
Journal Article
Open access
PDF file
MAMaru Ando
Maru Ando
MTMio Tsuchiya
Mio Tsuchiya
SIShun Itai
Shun Itai
TMTomomi Murayama
Tomomi Murayama
YKYuta Kurashina
Yuta Kurashina
HOHiroaki Onoe
Hiroaki Onoe
We present fluorescent Janus hydrogel microbeads for continuous glucose sensing with pH calibration. The Janus hydrogel microbeads, that consist of fluorescent glucose and pH sensors, were fabricated with a UV-assisted centrifugal microfluidic device. The microbead can calibrate the pH values of its surroundings and enables accurate measurements of glucose within various pH conditions. As a proof of concept, we succeeded in obtaining the accurate value of glucose concentration in a body-fluid-like sample solution. We believe that our fluorescent microbeads, with pH calibration capability, could be applied to fully implantable sensors for continuous glucose monitoring.